Exscientia plc Exscientia (NASDAQ: EXAI) and Sanofi Announces Strategic Research Partnership Exscientia plc (NASDAQ: EXAI) and Sanofi (NASDAQ: SNY) have inked a groundbreaking research partnership and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology,
